Skip to content

Study on peripheral biomarkers to predict brain injury in sepsis

Study on peripheral biomarkers to predict brain injury in sepsis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300069425
Enrollment
Unknown
Registered
2023-03-16
Start date
2022-06-22
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

non-sepsis:none

Sponsors

The Third Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patient aged >= 18 years; 2. Less than 24 h after admission; 3. Meeting the diagnostic criteria for sepsis (clear focus of infection; SOFA score >= 2 points): Determination of infection focus: respiratory tract infection, urinary tract infection, intestinal infection and other clear infection focus, except central nervous system infection focus; 4. Non-sepsis patients: patients with infection sites, such as skin, digestive tract, urinary tract, etc., but did not meet the diagnostic criteria for sepsis; 5. Informed consent of patients and their families to participate in the research project; 6. Able to communicate with researchers briefly and complete the assessment of relevant scales.

Exclusion criteria

Exclusion criteria: 1. Patients with primary central nervous system diseases (such as cerebral hemorrhage, cerebral infarction, cerebral trauma, etc.); 2. The patient has a pre-existing psychiatric or neurological condition (e.g., intracranial tumor); 3. Clear evidence of encephalitis/meningitis; 4. Disorders of consciousness and changes of mental state caused by acute encephalopathy caused by other reasons. Including metabolic encephalopathy, blood electrolyte disorder, toxic encephalopathy, central nervous system primary disease, and sedative sleep drug interference; 5. Antibiotics, hormones and other immunosuppressive drugs were used before admission; 6. Renal replacement therapy such as hemofiltration and hemodialysis; 7. Tumor, autoimmune disease, cirrhosis, uremia, etc.; 8. Recent history of blood transfusion; 9. Patients or family members refused to participate in this study.

Design outcomes

Primary

MeasureTime frame
sofa scale, Sequential Organ Failure Assessment;GCS, Glasgow Coma Scale;

Secondary

MeasureTime frame
Mechanical ventilation time;Length of ICU stay;Leukocyte Count;

Countries

China

Contacts

Public ContactLi Gong

The Third Xiangya Hospital of Central South University

ligong@csu.edu.cn+86 13467511233

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026